Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
about
Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell typesThe physiological action of picolinic Acid in the human brainKynurenine 3-Monooxygenase: An Influential Mediator of NeuropathologyKynurenines in the mammalian brain: when physiology meets pathologyHuman microglia convert l-tryptophan into the neurotoxin quinolinic acidNeurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.Induction of indolamine 2,3-dioxygenase in primary human macrophages by human immunodeficiency virus type 1 is strain dependent.Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?Tryptophan metabolites and brain disorders.The tryptophan kynurenine pathway, neopterin and IL-6 during vulvectomy and abdominal hysterectomy.Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malariaSerum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer.Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus.Characterization of the kynurenine pathway and quinolinic Acid production in macaque macrophages.Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration.Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge.NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice.The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders.Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.Towards amino acid recommendations for specific physiological and patho-physiological states in pigs.Excitotoxicity in the pathogenesis of autism.Sleep disturbance and kynurenine metabolism in depression.Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders.Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.Quinolinic acid and inflammation.Serum kynurenic acid is reduced in affective psychosis.Induction of pterin synthesis is not required for cytokine-stimulated tryptophan metabolism.4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients.Species and cell types difference in tryptophan metabolism.Neonatal asphyxia in rats: acute effects on cerebral kynurenine metabolism.Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism.Salivary cytokines in healthy adolescent girls: Intercorrelations, stability, and associations with serum cytokines, age, and pubertal stage.Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment.Shifting the balance of brain tryptophan metabolism elicited by isolation housing and systemic administration of lipopolysaccharide in mice.In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors.Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.Glia- and tissue-specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone.Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression.
P2860
Q24310976-1382A060-4470-4A68-971C-315319BEEA19Q24634995-AD743BE7-7AF4-4B16-A438-E82D3626E3A8Q26782867-D6213A55-BFE0-418C-A49F-AC7208DCB956Q27003296-8AD87FE0-AFCB-4EA9-B61B-6B8BA11952F9Q28379366-D6595B81-57D7-48FC-8ECC-3CD2D581801EQ30839124-AAE57B48-3549-4859-AB90-2B8EF6E2B6FDQ33803408-06F01F6E-E7E7-4883-B830-03B0CF791121Q34051382-60B94076-5302-416E-ADAA-CA1C9420E4E4Q34225314-69C67812-933A-45E0-B9A3-19E649230391Q34989490-70F0D5DB-8ED7-41D9-B707-FBE4939339AFQ35763798-58F002B3-D299-4B97-B416-023EF1451E44Q36644563-8C0042FB-C68C-4697-BD7B-1546F68C03E1Q36865674-6364EB95-6D02-474B-96B6-C6D1459D68DAQ36870449-C619338B-C459-48B4-830D-095FF85516F0Q36945216-4A1CD4FC-DBE4-4F6D-B218-6D69418215B8Q36945317-2D5D64BB-E782-4EAE-9B53-D92399DCEBFEQ37030206-21F38478-B954-4E38-97B7-76A5680966B0Q37318862-FB332B63-F432-4CB4-B4E4-6A76354F233EQ37892975-5A8B54DB-13E0-4DEF-BF20-76789937AAD1Q38011330-7CD2BC60-7597-4FD5-BDD2-194CFF1A1B23Q38052081-A9509F99-8DA8-4CE5-B6EC-98D40FD272F2Q38676972-9CDFEC0F-758B-42BE-B0B5-35EF9CA2803CQ38843539-0783979D-8E3B-43CC-A505-B5E7335CE426Q39653727-CD89EB9B-FC80-4AD4-8EBE-FEEE97D5B1C2Q40917147-86E712A4-5205-4214-9DBE-AF49EBB92A5BQ41173215-1BC6AEFA-6E8A-4EFA-A91D-7748FD7DA59BQ41520870-F392FE73-3F52-4E86-8D5E-0A7AF3DAFA73Q41561714-CD9AF182-6CE0-49B2-986E-A809B96EBCA2Q42495952-F90FB4FB-37D8-4997-A294-EEBB08FAC6E3Q42498228-4F8D21F3-8EDB-4895-B3BA-F4E6FE3BD339Q43066367-020036C5-3D44-4766-A292-22B9B82D112EQ43690548-58DA79D2-3C4F-460E-90B8-21EB0851F0F2Q43690832-B4DBE608-7596-46CF-84E7-DF752D9E55F8Q45005186-7CFCC856-8AE6-4939-AEBC-8E9E795D1CCCQ45307207-58DF3F8A-A35E-4FF0-B9D0-B2A7BE18147DQ46249577-37BE307C-1029-437F-A0B4-589179066D7BQ46634149-516808AF-6337-483C-A2DF-70354CC03DE5Q46790380-30F0F209-7CF3-4006-B946-7A6B17B40515Q47678641-FFA2C987-E90B-4B3E-A9A4-76825550FDBBQ47722395-9DA1F677-7256-40F7-AC40-E7F49300E149
P2860
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@ast
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@en
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@nl
type
label
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@ast
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@en
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@nl
prefLabel
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@ast
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@en
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@nl
P2093
P3181
P1433
P1476
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
@en
P2093
P3181
P356
10.1016/0306-4522(92)90467-G
P407
P577
1992-11-01T00:00:00Z